2Global guideline for Type 2 Diabetes[Z].International diabetes federation,2005.
3D.M.Nathan,J.B.Buse,M.B.Davidson,et al.Management of hyperglycaemia intype 2diabetes:a consensus algorithm for the initiation and adjustment of therapy[J].Diabetologia,2006,49:1711-1721.
4UK Prospective Diabetes study Group.Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes[J].BMJ,1998;317:703-713.
5UK Prospective Diabetes study Group.Efficacy of atenolol and captopril in reducing risk of both macrovascular and microvascular complication in type 2 diabetes.BMJ,1998,317:713-720.
6Diabetes Prevention Program Research Group.Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program[J].Diabetes Care,2005,28:888-894.
7Salpeter S.Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus[J].N Engl J Med,2006,333:541.
